NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
PAR:PAR-25-447.htmlOverview
- Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Program: Trans-Omics for Precision Medicine (TOPMed) 2.0
- Focus: Generate and share large-scale multi-omics data to uncover molecular mechanisms of heart, lung, blood, and sleep (HLBS) disorders, including rare diseases.
What this opportunity provides
- No direct funding t…
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership in research, training, and education to promote the prevention and treatment of heart, lung, blood and sleep disorders. NHLBI's mission covers many common diseases, such as heart disease and chronic respiratory dise…
Source
Tags
Similar opportunities
-
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
-
Access TOPMed resources to generate multi-omics data for heart, lung, blood, and sleep disorders (X01, no funding)
-
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
-
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
-
Notice of Funding Opportunity (NOFO) for NIH INCLUDE Project
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers